LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
Tim Reiner joins Mundipharmas regional office

Tim Reiner has been appointed as Mundipharma's Head of Business Development for Asia, Latin America and the Middle East/North Africa with effect from 1 June, 2013, to further strengthen the company's presence in key growth regions.

Tim joins Mundipharma Pte. Ltd. from McKinsey where he spent the last 7 years on the McKinsey Global Rotation Program, leading more than 55 consulting projects across pharmaceutical, consumer, and other healthcare and industrial clients. Since 2010, he was one of the leaders in McKinsey's EMEA Pharmaceutical and Medical Products Practice, and co-founded the Healthcare/Private Equity practice joint-venture.

During his tenure, in addition to his client service, he led the development of McKinsey's standard approach for pharmaceutical and medical product diligences, and served as faculty at McKinsey's internal private equity and due diligence trainings. Prior to McKinsey, Tim worked with a mid-market private equity fund and the University of Minnesota's Ventures Enterprise to identify investment opportunities in biopharmaceuticals and other industries.

Raman Singh, Regional Director, Asia Pacific, Latin America, Middle East and Africa, said, “We are delighted to have Tim on board with Mundipharma in Singapore, bringing his rich experience and proven leadership abilities in pharmaceutical and medical products practices across multiple important markets globally. Having him head our business development in Asia, Latin American, and the Middle East/North Africa will bring positive growth and help Mundipharma further strengthen our operations throughout these developing regions.”

Tim Reiner, who relocated to Singapore in June, said, “I’m excited to be joining Mundipharma, a company with such wide reach globally, and that has been delivering consistently high quality products in the field of pain management. It's great to be part of a company still very open to exploring new fields and dedicated to expanding its business for patients worldwide.”

Click here for the complete issue.


Credits to Sony Computer Entertainment and click here for behind the scenes.

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy